MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » AliveCor taps Google social SVP Gundotra for CEO | Personnel Moves

AliveCor taps Google social SVP Gundotra for CEO | Personnel Moves

By

MassDevice.com Personnel MovesAliveCor said yesterday it tagged former Google (NSDQ:GOOG) social senior veep Vic Gundotra as its new CEO, replacing current interim CEO Euan Thomson.

Gundotra served as senior veep at Google from 2011 to 2014, after joining as a veep in 2007. Gundotra was responsible for Google’s social networking and identity services, and is credited as being the “father” of Google Plus, Google’s social media network.

Prior to his work at Google, Gundotra spent 15 years at Microsoft (NSDQ:MSFT), where he sparked Microsoft’s switch from Win32 to the .NET programming model and served as GM for global developer outreach, including platform evangelism and strategy for core Microsoft products.

“I am thrilled to become part of the AliveCor team. What they have achieved throughout the past four years is tremendous. Being able to understand what is going on inside heart disease through data analytics and machine learning has the potential to change the way we think of and participate in our healthcare. I am looking forward to being on the forefront of consumerizing medicine and working with an extremely intelligent team with innovative products,” CEO Vic Gundotra said in a press release.

Thomson has served as San Francisco, Calif-based AliveCor’s interim CEO since August 2013, after joining the board in January earlier that year, the company said. During his period as interim CEO he aided the company in expanding FDA and CE mark clearances.

“My time at AliveCor has been an important and fulfilling chapter in my career. No one has done what we are doing. I am thankful for the opportunity to help develop products that are helping people across the world. I am pleased to welcome Vic who brings years of experience spanning consumer and technology products that will be of great value as AliveCor works to expand and diversify into different business models,” Thomson said in prepared remarks.

 

 Retrofit lures ex-BSX engineer Ahmed as senior data scientist
Retrofit said Monday it tagged ex-Boston Scientific (NYSE:BSX) software engineer Rezwan Ahmedas its new senior data scientist, leading the company’s data science initiatives including advancing its weight-loss platform.
Read more

 Ex-FDA chief of staff Esposito joins Covington & Burling
Covington & Burling said Monday it picked up former FDA chief of staff Denise Esposito as a partner for the firm and co-chair of its food & drug practice group. Esposito held several senior exec positions with the FDA between 2010 and 2015.
Read more

 Mela Sciences promotes Allgeier to CFO
Mela Sciences (NSDQ:MELA) said yesterday it promoted Christina Allgeier to CFO, replacing Robert Cook who resigned to pursue other matters. Allgeier joined Mela after it acquired Xtrac and Vtrac assets from PhotoMedex (NSDQ:PHMD).
Read more

 Ocular Therapeutix adds O’Shea board
Ocular Therapeutix (NSDQ:OCUL) said Monday it added former Sepracor prez and COO W. James O’Shea to its board of directors. Prior to his work at Sepracor, O’Shea held positions with AstraZeneca (NYSE:AZN).
Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • 5 of the latest cardiac tech insights out of ACC.21
    The American College of Cardiology’s 70th Annual Scientific Session has produced some positive news about some controversial cardiac tech. Drug-coated stents, which a 2018 study linked to late-stage death, were shown to be non-inferior to non-drug-coated stents in patients with peripheral arterial disease. And a new study of renal denervation that used a different methodology… […]
  • Viant expands ortho plant in France
    Viant announced today that it completed a more than $8 million expansion of its France-based Orthopedic Implant & Coating Center of Excellence. Foxborough, Mass.-based Viant’s Chaumont, France facility expansion includes a new building with a controlled-environment room and an investment in recently FDA-cleared vacuum plasma spray (VPS) coating technology, according to a news release. The… […]
  • How will clinical trials be conducted in the future?
    The COVID-19 lockdown compelled clinical trial managers and regulatory compliance officers to innovate in ensuring that critical testing moved forward while the world had shut down. With life shifting back, how much of these new measures will remain in place? Join us on Tuesday, May 18 on DeviceTalks Tuesdays to hear representatives from Medtronic, Hologic… […]
  • Edwards Lifesciences tricuspid valve reduced leakage in 98% of patients
    Edwards Lifesciences‘s Evoque tricuspid valve replacement system reduces tricuspid heart valve leakage to non-traceable or mild leakage in 98% of patients, according to a new study reported at the American College of Cardiology’s 70th Annual Scientific Session. Evoque is designed to replace native tricuspid valves without open-heart surgery. The valve is implanted using a minimally… […]
  • DTW Podcast: Getting to the heart of Boston Scientific’s peripheral business; How Hologic sees trials changing
    In this week’s episode of the DeviceTalks Weekly Podcast, Boston Scientific peripheral business EVP Jeff Mirviss explains why the specialty’s name doesn’t really reflect the importance of arteries, veins and other critical “highways” in the body. Mirviss explains where the peripheral business is headed, and why Boston Scientific is uniquely positioned to address the business.… […]
  • ReCor Medical has positive renal denervation study news
    ReCor Medical‘s renal denervation significantly reduced blood pressure among people with drug-resistant hypertension, according to a new study reported at the American College of Cardiology’s 70th Annual Scientific Session. The study news, announced yesterday, could suggest a turnaround in fortunes for renal denervation technology. One considered the next big thing in the medical device industry,… […]
  • CMS delays Medicare payments for breakthrough devices until December
    Medicare coverage for FDA-designated breakthrough medical devices will have to wait several more months, despite broad support. The Centers for Medicare and Medicaid Services (CMS) issued a final rule on Medicare Coverage of Innovative Technology (MCIT) in January, granting coverage for breakthrough devices the same day as their FDA approvals, for up to four years. Immediately… […]
  • This imaging device could be a breakthrough for breast cancer treatment
    OncoRes Medical’s system may detect cancer cells on a microscopic scale during a lumpectomy, potentially averting the need for a second breast cancer surgery. Having breast surgery to remove a cancerous lump is traumatic enough. Learning that you’ll need another operation to remove cancer cells that the surgeon couldn’t detect the first time only adds… […]
  • Americans apparently trust healthcare professionals more than FDA, CDC
    As the U.S. tries to reach a post-COVID-19 pandemic “normal,” Americans are placing more trust in nurses and doctors than agencies such as the CDC and FDA, according to a new survey from the Robert Wood Johnson Foundation and Harvard T.H. Chan School of Public Health. The survey — conducted Feb. 11 – March 15,… […]
  • May 2021 Issue: Unmasking the response to the next pandemic
    3M, others may have unmasked a solution to future N95 shortages The 10 largest orthopedic device companies in the world How big medtech fared during a year of COVID-19 Medtech moves beyond the pandemic The COVID-19 pandemic is still very much with us, and medtech companies continue churning out devices to meet coronavirus patient needs.… […]
  • FDA warns about consumer electronics and implanted devices
    The FDA is advising the public that certain consumer devices have high-field strength-magnets that can send medical devices into “magnet mode.” Magnets of this nature can affect the normal operations of implanted medical devices until the magnetic field is moved, according to the FDA news release. These medical devices are designed with a “magnet mode”… […]